Yang; Dexi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yang; Dexi.The latest application filed is for "factor xi activation inhibitors".
- Yang; Dexi - Livingston NJ
| Patent | Date |
|---|---|
| Factor Xi Activation Inhibitors App 20220235033 - Hicks; Jacqueline D. ; et al. | 2022-07-28 |
| Pyrrolidine Orexin Receptor Agonists App 20220144771 - Bogen; Stephane L. ; et al. | 2022-05-12 |
| Bicycloheptane Pyrrolidine Orexin Receptor Agonists App 20220056017 - BOGEN; Stephane L. ; et al. | 2022-02-24 |
| Metallo-beta-lactamase inhibitors and methods of use thereof Grant 11,207,312 - Pasternak , et al. December 28, 2 | 2021-12-28 |
| 5-alkyl pyrrolidine orexin receptor agonists Grant 11,098,029 - Bogen , et al. August 24, 2 | 2021-08-24 |
| Metallo-beta-lactamase Inhibitors And Methods Of Use Thereof App 20200375987 - Pasternak; Alexander ; et al. | 2020-12-03 |
| Metallo-Beta-Lactamase Inhibitors and Methods of Use Thereof App 20200281913 - Pasternak; Alexander ; et al. | 2020-09-10 |
| 5-alkyl Pyrrolidine Orexin Receptor Agonists App 20200255403 - Kind Code | 2020-08-13 |
| Metallo-beta-lactamase inhibitors Grant 10,544,130 - Bennett , et al. Ja | 2020-01-28 |
| Metallo-beta-lactamase Inhibitors App 20190144432 - Bennett; Frank ; et al. | 2019-05-16 |
| Metallo-.beta.-lactamase inhibitors Grant 10,227,331 - Bennett , et al. | 2019-03-12 |
| Metallo-beta-lactamase inhibitors Grant 10,221,163 - Bennett , et al. | 2019-03-05 |
| Metallo-beta-lactamase Inhibitors App 20180244656 - Bennett; Frank ; et al. | 2018-08-30 |
| Metallo-beta-lactamase Inhibitors App 20180179190 - Bennett; Frank ; et al. | 2018-06-28 |
| Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors Grant 9,839,642 - Tang , et al. December 12, 2 | 2017-12-12 |
| Metallo-beta-lactamase inhibitors Grant 9,708,336 - Mandal , et al. July 18, 2 | 2017-07-18 |
| Beta-tetrazolyl-propionic Acids As Metallo-beta-lactamase Inhibitors App 20170173035 - Tang; Haifeng ; et al. | 2017-06-22 |
| Metallo-beta-lactamase Inhibitors App 20160333021 - Mandal; Mihir ; et al. | 2016-11-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 